Live Breaking News & Updates on Therapeutics discovery

Stay updated with breaking news from Therapeutics discovery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Scientists unlock secrets of red blood cell transporter, potentially paving the way for new drugs

Scientists unlock secrets of red blood cell transporter, potentially paving the way for new drugs
phys.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phys.org Daily Mail and Mail on Sunday newspapers.

California , United-states , Berkeley , Yihan-zhao , Sezen-vatansever , Mihaly-mezei , Shifan-yang , Michaelj-capper , Raul-habib , Daniel-wacker , Avner-schlessinger , Gregory-zilberg

New research sheds light on role of KRAS mutations in pancreatic cancer

Researchers at The University of Texas MD Anderson Cancer Center have uncovered a functional role for KRAS mutations in pancreatic cancer and rapidly translated these findings into a novel therapeutic approach combining a KRAS G12D inhibitor with immune checkpoint inhibitors for early- and late-stage KRAS G12D-mutant pancreatic cancer.

Texas , United-states , Sid-richardson , Kathleen-mcandrews , Raghu-kalluri , Krishnan-mahadevan , Anirban-maitra , Timothy-heffernan , Lily-ramsey , National-cancer-institute , Md-anderson-translational-research-to-advance-therapeutics , Khalifa-bin-zayed-al-nahyan-foundation

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Krishnan-mahadevan , Kathleen-mcandrews , Raghu-kalluri , Anirban-maitra , Timothy-heffernan , Md-anderson-translational-research-to-advance-therapeutics , National-cancer-institute , Sidw-richardson-foundation , Khalifa-bin-zayed-al-nahyan-foundation , Lustgarten-foundation , Oncology-research

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Texas , United-states , Anirban-maitra , Kathleen-mcandrews , Krishnan-mahadevan , Timothy-heffernan , Raghu-kalluri , Oncology-research , University-of-texas-md-anderson-cancer-center , Md-anderson-translational-research-to-advance-therapeutics , Cancer-center , Developmental-celland-cancer-cell

Immunotherapy-KRAS Combo Wipes Out Advanced Pancreatic Cancer

Immunotherapy-KRAS Combo Wipes Out Advanced Pancreatic Cancer
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Texas , United-states , Sid-richardson , Kathleen-mcandrews , Anirban-maitra , Timothy-heffernan , Krishnan-mahadevan , Raghu-kalluri , Oncology-research , National-cancer-institute , University-of-texas-md-anderson-cancer-center , Sidw-richardson-foundation

Combining immunotherapy with KRAS inhibitor e

Researchers at The University of Texas MD Anderson Cancer Center have uncovered a functional role for KRAS mutations in pancreatic cancer and rapidly translated these findings into a novel therapeutic approach combining a KRAS G12D inhibitor with immune checkpoint inhibitors for early- and late-stage KRAS G12D-mutant pancreatic cancer. The combination therapy led to durable tumor elimination and significantly improved survival outcomes in preclinical models, leading to the launch of a Phase I clinical trial.

Houston , Texas , United-states , Sid-richardson , Krishnan-mahadevan , Kathleen-mcandrews , Anirban-maitra , Timothy-heffernan , Raghu-kalluri , National-cancer-institute , Anderson-translational-research-to-advance-therapeutics , University-of-texas-md-anderson-cancer-center

University of Minnesota – Twin Cities — Faculty Openings in Genetics, Cell Biology, & Development : The Journal of Blacks in Higher Education

University of Minnesota – Twin Cities — Faculty Openings in Genetics, Cell Biology, & Development : The Journal of Blacks in Higher Education
jbhe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jbhe.com Daily Mail and Mail on Sunday newspapers.

Jess-stuart , Department-of-genetics , Biotechnology-institute , University-of-minnesota , Lillehei-heart-institute , Institute-of-engineering , Institute-for-therapeutics-discovery-development , Epigenetics-consortium , College-of-biological-sciences , School-medical-discovery-teams , Cell-biology , Associate-professor

Tenure Track Assistant Professor job with University of Minnesota College of Pharmacy

Tenure Track Assistant Professor job in Minneapolis, Minnesota with University of Minnesota College of Pharmacy. Apply Today.

University-of-minnesota , Minnesota , United-states , Max-adamitis , Natalia-tretyakova , Epigenetics-consortium , Institute-for-translational-neuroscience , Academic-health-center , Memory-research , N-bud-grossman-center , Masonic-cancer-center , Magnetic-resonance-research

MD Anderson, Nexo Therapeutics Partner to Advance New Therapies

MD Anderson, Nexo Therapeutics Partner to Advance New Therapies
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Texas , United-states , Andrew-phillips , Tim-heffernan , Oncology-research , University-of-texas-md-anderson-cancer-center , Md-anderson-translational-research-to-advance-therapeutics , Cancer-center , Nexo-therapeutics , Translational-research , Advance-therapeutics , Covalent-discovery

MD Anderson and Nexo Therapeutics partner to advance new cancer therapies against previously undruggable targets

The University of Texas MD Anderson Cancer Center and Nexo Therapeutics today announced a multi-year strategic collaboration that aligns the innovative technology and capabilities of each organization at the earliest stages of drug discovery and development to rapidly advance impactful new cancer therapies against previously undruggable targets.

Texas , United-states , Danielle-ellis , Tim-heffernan , Andrew-phillips , University-of-texas-md-anderson-cancer-center , Md-anderson-translational-research-to-advance-therapeutics , Oncology-research , Cancer-center , Nexo-therapeutics , Translational-research , Advance-therapeutics